EMRUXTIV
Live / Applied — Fifth extension granted (statement of use) (as of 30 Dec 2025)
What this means for you
Not registered yet, but its 07 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97447303
- Mark type
- Stylized text
- Filed
- 07 Jun 2022
- Published for opposition
- 24 Jan 2023
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of multiple sclerosis
Owner
- Principia Biopharma Inc., Bridgewater, NJ, US
- Principia Biopharma Inc., Bridgewater, NJ, US
Prosecution history
- 31 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Dec 2025 — SOU EXTENSION 5 GRANTED
- 06 Aug 2025 — SOU EXTENSION 5 FILED
- 23 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 26 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Feb 2025 — SOU EXTENSION 4 GRANTED
- 07 Feb 2025 — SOU EXTENSION 4 FILED
- 07 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jul 2024 — SOU EXTENSION 3 GRANTED